Fixed-Dose Combination Drug Approvals, Patents and Market Exclusivities Compared to Single Active Ingredient Pharmaceuticals
about
Fixed-Dose Combination Drug Approvals, Patents and Market Exclusivities Compared to Single Active Ingredient Pharmaceuticals
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Fixed-Dose Combination Drug Ap ...... ive Ingredient Pharmaceuticals
@ast
Fixed-Dose Combination Drug Ap ...... ive Ingredient Pharmaceuticals
@en
Fixed-Dose Combination Drug Ap ...... ive Ingredient Pharmaceuticals
@nl
type
label
Fixed-Dose Combination Drug Ap ...... ive Ingredient Pharmaceuticals
@ast
Fixed-Dose Combination Drug Ap ...... ive Ingredient Pharmaceuticals
@en
Fixed-Dose Combination Drug Ap ...... ive Ingredient Pharmaceuticals
@nl
prefLabel
Fixed-Dose Combination Drug Ap ...... ive Ingredient Pharmaceuticals
@ast
Fixed-Dose Combination Drug Ap ...... ive Ingredient Pharmaceuticals
@en
Fixed-Dose Combination Drug Ap ...... ive Ingredient Pharmaceuticals
@nl
P2093
P2860
P3181
P1433
P1476
Fixed-Dose Combination Drug Ap ...... ive Ingredient Pharmaceuticals
@en
P2093
Enrique Seoane-Vazquez
Rosa Rodriguez-Monguio
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0140708
P407
P577
2015-01-01T00:00:00Z